Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

210.85
Delayed Data
As of Dec 14
 -3.70 / -1.72%
Today’s Change
124.82
Today|||52-Week Range
230.72
+64.68%
Year-to-Date

Today’s Trading

Previous close214.55
Today’s open215.06
Day’s range210.53 - 215.80
Volume577,539
Average volume (3 months)751,950
Market cap$31.3B
Data as of 4:00pm ET, 12/14/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+12.42%
Earnings growth (next 5 years)+15.60%
Revenue growth (last year)+8.05%
P/E ratio40.2
Price/Sales7.90
Price/Book14.28

Competitors

----
BIVVBioverativ Inc0.000.00%
EXASExact Sciences Corp-0.66-1.27%
BLUEbluebird bio Inc-0.55-0.30%
Data as of 4:00pm ET, 12/14/2017

Financials

Next reporting dateJanuary 30, 2018
EPS forecast (this quarter)$1.18
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Executive VP-Operations, Products &
Strategy
Ostadan Omead
Corporate headquarters
San Diego, California

Forecasts